1-4 of 4
Brendan J. Jenkins
Close
Sort by
Journal Articles

Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27

Christine Brender, Gillian M. Tannahill, Brendan J. Jenkins, Joel Fletcher, Ruth Columbus, Christiaan J. M. Saris, Matthias Ernst, Nicos A. Nicola, Douglas J. Hilton, Warren S. Alexander, Robyn Starr
Journal: Blood
Blood (2007) 110 (7): 2528–2536.
https://doi.org/10.1182/blood-2006-08-041541
Published: 2007
Journal Articles

Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis

Brendan J. Jenkins, Andrew W. Roberts, Claire J. Greenhill, Meri Najdovska, Therese Lundgren-May, Lorraine Robb, Dianne Grail, Matthias Ernst
Journal: Blood
Blood (2006) 109 (6): 2380–2388.
https://doi.org/10.1182/blood-2006-08-040352
Published: 2006
Includes: Supplemental data
Journal Articles

The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis

Brendan J. Jenkins, Andrew W. Roberts, Meri Najdovska, Dianne Grail, Matthias Ernst
Journal: Blood
Blood (2005) 105 (9): 3512–3520.
https://doi.org/10.1182/blood-2004-09-3751
Published: 2005
Includes: Supplemental data
Journal Articles

Saturation Mutagenesis of the β Subunit of the Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor Shows Clustering of Constitutive Mutations, Activation of ERK MAP Kinase and STAT Pathways, and Differential β Subunit Tyrosine Phosphorylation

Brendan J. Jenkins, Timothy J. Blake, Thomas J. Gonda
Journal: Blood
Blood (1998) 92 (6): 1989–2002.
https://doi.org/10.1182/blood.V92.6.1989
Published: 1998